Comparative in vitro antimicrobial procedural efficacy for susceptibility of Staphylococcus aureus, Escherichia coli and Pseudomonas species to chloramphenicol, ciprofloxacin and cefaclor

British Journal of Biomedical Science

Volumn 65, Issue 4, 2008, Pages 178-183

  Saxena, Sanjai ^a   Gomber, C ^a  

^a THAPAR UNIVERSITY   (India)

Author keywords

Antimicrobial susceptibility testing; Escherichia coli; Pseudomonas; Spectrophotometry; Staphylococcus aureus

Indexed keywords

ANTIBIOTIC AGENT; CEFACLOR; CHLORAMPHENICOL; CIPROFLOXACIN; FORMAZAN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM CULTURE; BACTERIUM ISOLATION; BROTH DILUTION; CONTROLLED STUDY; CORRELATION ANALYSIS; DISK DIFFUSION; DRUG EFFICACY; EPSILOMETER TEST; ESCHERICHIA COLI; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS; REDUCTION; RELIABILITY; SPECIES DIFFERENCE; STAPHYLOCOCCUS AUREUS;

ESCHERICHIA COLI; PSEUDOMONAS; STAPHYLOCOCCUS AUREUS;

EID: 58149522608     PISSN: 09674845     EISSN: None     Source Type: Journal    
DOI: 10.1080/09674845.2008.11732825     Document Type: Article

References (25)

1. Kahlmeter G, Brown DEJ, Goldstein FW et al. European harmonization of MIC breakpoints for antimicrobial susceptibility testing of bacteria. J Antimicrob Chemother 2003; 52: 145-8.
2. Andrews JM. Determination of minimum inhibitory concentrations. J Antimicrob Chemother 2004; 48 (Suppl 1): 5-16.
3. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial disk susceptibility testing. NCCLS Publication M2-A6. Wayne, PA: NCCLS, 1997.
4. Moran GJ, Amii RN, Abrahamian FM, Talan DA. Methicillin-resistant Staphylococcus aureus in community-acquired skin infections. Emerg Infect Dis 2005; 11: 928-30.
5. Yamazaki Y, Hirai K, Honda T. Pseudomembranous tracheobronchitis caused by methicillin-resistant Staphylococcus aureus. Scand J Infect Dis 2002; 34: 211-21.
6. Watanabe H, Masaki L, Asoh N et al. Molecular analysis of methicillin-resistant Staphylococcus aureus as a causative agent of bronchopulmonary infection: relation to colonization in the upper respiratory tract. J Clin Microbiol 2000; 38: 3867-9.
7. Vandenesch F, Timothy N, Enright M et al. Community-acquired methicillin-resistant Staphylococcus aureus carrying Panton-Valentine leukocidin genes: worldwide emergence. Emerg Infect Dis 2003; 9: 978-84.
8. Nakhjavani FA, Mirsalehian A, Kazemi, B, Mirafshar, M, Jabalameli F. Antimicrobial susceptibility testing for Escherichia coli strains to fluoroquinolones in urinary tract infections. Iran J Public Health 2007; 36 (71): 89-92.
9. Deretic V. Pseudomonas aeruginosa infections. In: Nataro JP, Blaser MJ, Cunningham-Rundles S eds. Persistent bacterial infections. Washington DC: American Society for Microbiology, 2000: 305-26.
10. Pukatzki S, Kersin RH, Mekalanos JJ. The human pathogen Pseudomonas aeruginosa utilizes conserved virulence pathways to infect the social amoeba Dictyostelium discoideum. Proc Nat Acad Sci USA 2002; 39 (5): 3159-64.
11. Turng B, Thomas V, Lilli H, Wulff S, Wiles T. Comparative studies of antibiotic susceptibility of Stenotrophomonas maltophilia with trimethoprim/sulphonamethoxazole using different testing methodologies. In: Proceedings of the 9th European Congress of Clinical Microbiology and Infectious Diseases; 1999, Berlin, Germany.
12. Kelly LM, Jacobs MR, Appelbaum PC. Comparison of agar dilution, microdilution, E-test and disk diffusion methods for testing activity of cefditoren against Streptococcus pneumoniae. J Clin Microbiol 1999; 37 (10): 3296-9.
13. Baker CN, Stocker SA, Culver DH, Thornsberry C. Comparison of the E-test to agar dilution, broth microdilution and agar diffusion susceptibility testing techniques by using a special challenge set of bacteria. J Clin Microbiol 1991; 29 (3): 533-8.
14. Eucast Definitive Document E.Def.3.1. European Committee for Antimicrobial Susceptibility Testing. Determination of minimum inhibitory concentrations (MICs) of antibacterial agents by agar dilution. Clin Microbiol Infect 2000; 6: 509-515.
15. National Committee for Clinical Laboratory Standards. Performance Standards for Antimicrobial Disc Susceptibility Tests Document No. NCCLS 2002; M100-S12.
16. Pettit RK, Weber CA, Kaen MJ et al. Microplate alamar blue assay for Staphylococcus epidermidis biofilms susceptibility testing. Antimicrob Agents Chemother 2005; 49 (7): 2612-7.
17. Baker CN, Tenover FC. Evaluation of alamar colorimetric broth microdilution susceptibility testing method for staphylococci and enterococci. J Clin Microbiol 1996; 34 (11): 2654-9.
18. Murray PR, Niles AC, Heeren RL. Comparison of a highly automated 5-h susceptibility testing system, the Cobas-Bact, with two reference methods: Kirby-Bauer disk diffusion and broth microdilution. J Clin Microbiol 1987; 25 (12): 2372-7.
19. Kohner PC, Patel R, Uhi J et al. Comparison of agar dilution, broth microdilution, E-test, disk diffusion and automated Vitek methods for testing susceptibilities of Enteracoccus spp. to vancomycin. J Clin Microbiol 1997; 35 (12): 3258-63.
20. Marley EF, Mohla C, Campos JM. Evaluation of E-Test for determination of antimicrobial MICs for Pseudomonas aeruginosa isolates from cystic fibrosis patients. J Clin Microbiol 1995; 33 (12): 3191-3.
21. Jones RN, Ferraro MJ, Reller LB, Schreckenberger PC, Swenson JM, Sader HS. Multicenter studies of tigecycline disk diffusion susceptibility results for Acinetobacter spp. J Clin Microbiol 2007; 45 (1): 227-30.
22. Hall G, Heimdahl A, Nord CE. Comparison of E-test and agar dilution methods for determining antibiotic susceptibilities of anaerobic bacteria and viridans streptococci isolated from blood. Anaerobe 1998; 4 (1):29-33.
23. van der Heijden IM, Levin AS, De Pedri EH et al. Comparison of disc diffusion, Etest and broth microdilution for testing susceptibility of carbapenem-resistant P. aeruginosa to polymyxins. Ann Clin Microbiol Antimicrob 2007, 6: 8.
24. Di Bonaventura GD, D'Antonio DD, Catamo G, Ballone E, Piccolomini R. Comparison of Etest, agar dilution, broth microdilution and disc diffusion methods for testing in vitro activity of levofloxacin against Staphylococcus spp. isolated from neutropenic cancer patients. Int J Antimicrob Agents 2002; 19 (2): 147-54.
25. Manoharan A, Pai R, Shankar V, Thomas K, Lalitha MK. Comparison of disc diffusion and E-test methods with agar dilution for antimicrobial susceptibility testing of Haemophilus influenzae. Indian J Med Res 2003; 117: 81-7.